Opioid Treatment Program Licensing and Certification

OTP Licensing and Certification

The licensing and certification process is directed by RCW 71.24.590 and WAC 246-341-0300. The licensing steps include:

The department will provide public notice to all appropriate media outlets in the community in which the facility is proposed to be located that states the applicant is proposing a facility in that community. The notice will also be posted to the Proposed OTP webpage along with a copy of the OTP’s Community Relations Plan.

Mobile/Fixed-Site Medication Units

OTP Fixed-Site and Medication Units

OTP Mobil Units

Contact Information 

Questions about OTP licensing or certification requirements in chapter 246-341 WAC:

Michelle Weatherly
Facilities program manager
Email Michelle.weatherly@doh.wa.gov 
Phone: 360-236-2992

State Opioid Treatment Authority (SOTA):

Jessica Blose
Washington State Health Care Authority
Email Jessica.blose@hca.wa.gov 
Phone: 360-643-7850

Questions about the Pharmacy Quality Assurance Commission Drug Other Controlled Substance registration, email WSPQAC@doh.wa.gov (WSPQAC@doh.wa.gov) 

Questions about a OTP application status, email HSQAFC@doh.wa.gov (HSQAFC@doh.wa.gov) 

Questions about the DEA approval process, email Seattle.diversion@dea.gov (seattle.diversion@dea.gov) 

Resources

Washington state regulations

Washington state laws

  • RCW 71.24.560 – Opioid Treatment Programs – Pregnant Individuals – Information and education.
  • RCW 71.24.585 – Opioid and substance use disorder treatment – State response.
  • RCW 71.24.587 – Opioid use disorder treatment – Possession or use of lawfully prescribed medication – Declaration by state.
  • RCW 71.24.589 – Substance use disorders – Law enforcement assisted diversion – Pilot project.
  • RCW 71.24.590 – Opioid treatment – Program licensing or certification by department, department duties – Use of medications by program – Definition.
  • RCW 71.24.593 – Opioid use disorder treatment – Care of individuals and their newborns – Authority recommendations required.
  • RCW 71.24.594 – Opioid overdose reversal medications – Education – Distribution – Labeling – Liability (Effective January 1, 2022).
  • RCW 71.24.595 – Statewide treatment and operating standards for opioid treatment programs – Evaluation and report.
  • RCW 71.24.597 – Opioid overdose reversal medication – Coordinated purchasing and distribution.

Federal regulations and guidance